Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tail-anchoring of Proteins in the ER Membrane01:45

Tail-anchoring of Proteins in the ER Membrane

2.8K
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
2.8K
The Proteasome01:13

The Proteasome

1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome02:18

The Proteasome

7.8K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
7.8K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

4.3K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.3K
Protein Modifications in the RER01:26

Protein Modifications in the RER

5.6K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.6K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

8.8K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicyclic D-Stereospecific Hydrolase Dimer With High Sustained Activity.

Angewandte Chemie (International ed. in English)·2026
Same author

Total Synthesis and Structural Revision of Keenamide A.

Journal of natural products·2026
Same author

Mechanism of SHP2 activation by bis-Tyr-phosphorylated Gab1.

Structure (London, England : 1993)·2025
Same author

Strategies for mitigating radiation damage and improving data completeness in 3D electron diffraction of protein crystals.

Acta crystallographica. Section D, Structural biology·2025
Same author

Preparing submicrometer crystals for electron diffraction.

Nature protocols·2024
Same author

Ubiquitin-derived artificial binding proteins targeting oncofetal fibronectin reveal scaffold plasticity by β-strand slippage.

Communications biology·2024

Related Experiment Video

Updated: May 3, 2026

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.5K

N-terminal protein modification by substrate-activated reverse proteolysis.

Sandra Liebscher1, Michael Schöpfel, Tobias Aumüller

  • 1Institute of Biochemistry/Biotechnology, Martin-Luther-University Halle-Wittenberg, Kurt-Mothes-Strasse 3, 06120 Halle/Saale (Germany).

Angewandte Chemie (International Ed. in English)
|February 13, 2014
PubMed
Summary

Researchers developed a highly specific trypsin variant for precise protein modification. This enzyme variant enables selective N-terminal labeling of diverse proteins under native conditions, overcoming previous limitations in protein bioconjugation.

Keywords:
biocatalysisbioconjugationprotein modificationproteinasesreverse proteolysis

More Related Videos

Reconstitution of Msp1 Extraction Activity with Fully Purified Components
05:52

Reconstitution of Msp1 Extraction Activity with Fully Purified Components

Published on: August 10, 2021

2.1K
Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
10:12

Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications

Published on: April 21, 2023

5.0K

Related Experiment Videos

Last Updated: May 3, 2026

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.5K
Reconstitution of Msp1 Extraction Activity with Fully Purified Components
05:52

Reconstitution of Msp1 Extraction Activity with Fully Purified Components

Published on: August 10, 2021

2.1K
Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
10:12

Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications

Published on: April 21, 2023

5.0K

Area of Science:

  • Biochemistry
  • Protein Chemistry
  • Enzymology

Background:

  • Site-specific protein modification is crucial for research but challenging.
  • Enzymatic methods offer selectivity but often suffer from limited specificity and competing hydrolysis.
  • Proteinases can catalyze ligation but are hindered by reversible reactions.

Purpose of the Study:

  • To design and apply a highly specific trypsin variant for selective protein modification.
  • To enable site-specific bioconjugation of diverse proteins with various reagents.
  • To overcome the limitations of hydrolysis reactions in enzymatic protein ligation.

Main Methods:

  • Engineered a novel trypsin variant with altered specificity.
  • Utilized the variant for N-terminal modification of diverse proteins.
  • Characterized the variant's activation mechanism and reaction conditions.

Main Results:

  • The trypsin variant selectively modifies N-terminal residues of various proteins.
  • Modification proceeds quantitatively under native, aqueous conditions.
  • The variant possesses a disordered activation domain that suppresses hydrolysis until substrate binding.

Conclusions:

  • The engineered trypsin variant provides a robust tool for site-specific protein bioconjugation.
  • This method overcomes challenges associated with enzymatic hydrolysis in protein modification.
  • The variant's design offers a new strategy for developing highly specific enzymatic tools.